scispace - formally typeset
Open AccessJournal ArticleDOI

Splicing Outcomes of 5' Splice Site GT>GC Variants That Generate Wild-Type Transcripts Differ Significantly Between Full-Length and Minigene Splicing Assays.

TLDR
In this article, a meta-analysis of human disease-associated 5' splice site GT>GC (i.e., +2T>C) variants and a cell culture-based full-length gene splicing assay (FLGSA) is presented.
Abstract
Combining data derived from a meta-analysis of human disease-associated 5' splice site GT>GC (i.e., +2T>C) variants and a cell culture-based full-length gene splicing assay (FLGSA) of forward engineered +2T>C substitutions, we recently estimated that ∼15-18% of +2T>C variants can generate up to 84% wild-type transcripts relative to their wild-type counterparts. Herein, we analyzed the splicing outcomes of 20 +2T>C variants that generate some wild-type transcripts in two minigene assays. We found a high discordance rate in terms of the generation of wild-type transcripts, not only between FLGSA and the minigene assays but also between the different minigene assays. In the pET01 context, all 20 wild-type minigene constructs generated the expected wild-type transcripts; of the 20 corresponding variant minigene constructs, 14 (70%) generated wild-type transcripts. In the pSPL3 context, only 18 of the 20 wild-type minigene constructs generated the expected wild-type transcripts whereas 8 of the 18 (44%) corresponding variant minigene constructs generated wild-type transcripts. Thus, in the context of a particular type of variant, we raise awareness of the limitations of minigene splicing assays and emphasize the importance of sequence context in regulating splicing. Whether or not our findings apply to other types of splice-altering variant remains to be investigated.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Characterization of a possible founder synonymous variant in TECTA in multiple individuals with autosomal recessive hearing loss

TL;DR: This study demonstrates that synonymous variants need careful splicing assessment and support from additional testing methodologies to determine their clinical impact, and suggests that this synonymous variant is likely pathogenic for TECTA-associated autosomal recessive hearing loss.
Journal ArticleDOI

Minigene splicing assays reveal new insights into exonic variants of the <i>SLC12A3</i> gene in Gitelman syndrome

TL;DR: Wang et al. as discussed by the authors analyzed 342 previously presumed SLC12A3 missense variants using bioinformatics programs and identified candidate variants that may alter the splicing of pre-mRNA through minigene assays.
Journal ArticleDOI

Counteracting the Common Shwachman–Diamond Syndrome-Causing SBDS c.258+2T>C Mutation by RNA Therapeutics and Base/Prime Editing

TL;DR: In this article , the authors investigated the molecular mechanisms underlying aberrant SBDS splicing and showed that SBDS exon 2 is dense in splicing regulatory elements and cryptic splice sites, complicating proper 5′ss selection.
Posted ContentDOI

HiFENS: High-throughput FISH detection of endogenous pre-mRNA splicing isoforms

TL;DR: High throughput FISH Detection of ENdogenous Splicing Isoforms, a high-throughput imaging assay based on hybridization chain reaction and used to screen for cellular factors that regulate alternative splicing of endogenous genes to demonstrate optimized detection with high specificity of endogenous splicing isoforms and multiplexing of probes for accurate detection of splicing outcomes with single cell resolution.
Journal ArticleDOI

HiFENS: high-throughput FISH detection of endogenous pre-mRNA splicing isoforms

TL;DR: HiFENS as mentioned in this paper is a high throughput FISH detection of endogenous splicing isoforms, a high-throughput imaging assay based on hybridization chain reaction (HCR) and used HiFENS to screen for cellular factors that regulate alternative splicing of endogenous genes.
References
More filters
Journal ArticleDOI

RNA and Disease

TL;DR: The discovery of disease-causing mutations in RNAs is yielding a wealth of new therapeutic targets, and the growing understanding of RNA biology and chemistry is providing new RNA-based tools for developing therapeutics.
Journal ArticleDOI

HGVS Recommendations for the Description of Sequence Variants: 2016 Update

TL;DR: The current recommendations, HGVS version 15.11, are presented, and briefly summarize the changes that were made since the 2000 publication, with most focus on removing inconsistencies and tightening definitions allowing automatic data processing.
Journal ArticleDOI

RNA mis-splicing in disease

TL;DR: An overview of RNA splicing mechanisms is provided followed by a discussion of disease-associated errors, with an emphasis on recently described mutations that have provided new insights into splicing regulation.
Journal ArticleDOI

Context-dependent control of alternative splicing by RNA-binding proteins

TL;DR: Some of the emerging rules that govern the highly context-dependent and combinatorial nature of alternative splicing regulation are described.
Related Papers (5)